Company Search:
Advanced Search
Sponsored Links
Cellectis SA - ADR Company Snapshot
Cellectis SA - ADR operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellectis SA - ADR with three other companies in this sector in the United States: Pfenex Inc (2016 sales of $60.19 million of which 100% was Biotechnology), Aduro Biotech Inc ($50.68 million of which 100% was ), and Luna Innovations Incorporated ($59.21 million ).

Sales Analysis. Cellectis SA - ADR reported sales of $56.30 million for the year ending December of 2016. This represents a decrease of 9.5% versus 2015, when the company's sales were $62.19 million.
  Stock Performance Chart for Cellectis SA - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 29.48
(Figures in U.S. Dollars)
1 Week 0.5%   13 Weeks 2.3%  
4 Weeks -3.0%   52 Weeks 68.3%  
Cellectis SA - ADR Key Data:
  Ticker: CLLS Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 56,297,956
(Year Ending Jan 2017).
Employees: 89
  Currency: U.S. Dollars Market Cap: 1,055,486,296
  Fiscal Yr Ends: December Shares Outstanding: 35,803,470
  Share Type: Closely Held Shares: 3,354,944
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.